Nanoparticle Delivery Platforms for Controlled Inhibition of CRISPR Gene Editing.
Conference
·
OSTI ID:1648796
Abstract not provided.
- Research Organization:
- Sandia National Lab. (SNL-CA), Livermore, CA (United States); Sandia National Lab. (SNL-NM), Albuquerque, NM (United States)
- Sponsoring Organization:
- Defense Advanced Research Projects Agency (DARPA)
- DOE Contract Number:
- AC04-94AL85000
- OSTI ID:
- 1648796
- Report Number(s):
- SAND2019-5369D; 675484
- Resource Relation:
- Conference: Proposed for presentation at the Safe Genes Phase 2 kickoff meeting held May 7-8, 2019 in Bethesda, Maryland, United States.
- Country of Publication:
- United States
- Language:
- English
Similar Records
Verification of CRISPR-Cas9 Gene Editing.
Mesoporous silica nanoparticle supported lipid bilayers for individual leukemia cell targeting and CRISPR delivery.
Controlling CRISPR via RNA Delivery using Lipid Nanoparticles.
Conference
·
Mon Jul 01 00:00:00 EDT 2019
·
OSTI ID:1648796
+2 more
Mesoporous silica nanoparticle supported lipid bilayers for individual leukemia cell targeting and CRISPR delivery.
Conference
·
Sat Sep 01 00:00:00 EDT 2018
·
OSTI ID:1648796
Controlling CRISPR via RNA Delivery using Lipid Nanoparticles.
Conference
·
Sat May 01 00:00:00 EDT 2021
·
OSTI ID:1648796
+2 more